The overexpression and alternative splicing of calcium-activated potassium channel subunit alpha-1 (KCNMA1) that encodes large-conductance calcium-activated voltage-sensitive potassium (BK Ca ) channels are implicated in the development of human cancers. Dysfunctional angiogenesis in hypoxic tumors is a challenge to intravenous anticancer drug treatments. Hypoxic factors also lead to abnormal vascular functions posing hurdle for anticancer drug delivery to tumors. The aim of this study was to explore the role of BK Ca channels in tumor angiogenesis, specifically with regard to release of vascular endothelial growth factor (VEGF). Materials and Methods: We subjected the glioma cells under hypoxia and normoxia and studied the expression and activity of BK Ca channels in in vitro and in vivo tumor models. Then, we studied the proangiogenic factor, VEGF, in tumors and monitored the neoangiogenic process. The study protocol was approved by the Institutional Animal Care and Use Committee, Mercer University, Atlanta, GA, USA (approved No. A0706007_01) on July 20, 2007. Results: We presented in vivo and cell based in vitro experimental evidence on the direct and indirect interactions of BK Ca channels with VEGF signaling. There was evidence that under hypoxia, glioma cells overexpressed KCNMA1 and increased VEGF secretion. By inhibiting KCNMA1, we showed that VEGF secretion was significantly reduced, thus potentially controlling angiogenesis, which has implications for vascular permeability and anticancer drug delivery. Moreover, there were differences in alternate splicing of KCNMA1 between normal and malignant cells under hypoxia and normoxia. Conclusion: We conclude that BK Ca channels regulate hypoxia-induced angiogenesis. Therefore, serious effort is needed to better understand the molecular mechanisms of BK Ca channelopathies triggering angiogenesis and progression of glioma. The modulators of BK Ca channels could be viable in new anticancer therapeutics.
intRoduCtion
Cancer is a chronic disease characterized by uncontrolled cell growth. [1] Cancer cells typically go through four stages -initiation, proliferation, invasion, and metastasis. There are over 100 different types of cancer, and each is classified by the type of cells that are initially affected. [2] Cancer cells divide uncontrollably to form lumps or masses of tissue called tumors that can grow and interfere with several bodily functions. Cell signaling involving vascular endothelial growth factor (VEGF) and its VEGF receptor (VEGFR) plays a major role in cancer progression by promoting new blood vessels formation called neoangiogenesis. [3] Disruption of the genes encoding either VEGF or any of the three receptors of the VEGF family results in embryonic lethality because of failure of blood vessel development. [4] VEGFR2 is the main signal transducing VEGFR for angiogenesis and mitogenesis of endothelial cells, which is directly related to cell cancer. VEGFs are combined with VEGFRs to activate the VEGF Inflection point in glioma growth and angiogenesis driven by potassium channels signaling cascade leading to angiogenesis. As shown in Table 1 , specific isoforms of VEGFs are combined with specific VEGFRs to regulate several critical cell functions and also impact on human health and diseases. [5] [6] [7] [8] VEGF can be detected in both plasma and serum samples of patients, with much higher level in serum. Platelets release VEGF upon aggregation and may be a major source of VEGF delivery to tumors. [9] Many tumors release cytokines that can stimulate the production of megakaryocytes in the marrow and elevate the platelet count. This can result in an indirect increase of VEGF delivery to tumors. [10, 11] The autocrine VEGF signaling is crucial for tumor initiation and transformation into highly aggressive cancers. [3] The blocking of autocrine VEGF secretion provides a promising strategy to develop new therapeutic approaches. [12] VEGF is implicated in several other pathological conditions associated with enhanced angiogenesis, such as cancer, psoriasis, and rheumatoid arthritis. Direct role of VEGF in tumor growth has been shown using dominant negative VEGFRs to block in vivo proliferation, as well as blocking antibodies to VEGF or to VEGFR2. [13] Interference with VEGF function by targeting the VEGF signaling pathway is a major interest in drug development for blocking angiogenesis in primary and metastatic brain tumors [ Figure 1 ].
The calcium-activated voltage-sensitive potassium (BK Ca ) channels interact with a variety of proteins both at the plasma membrane and with intracellular organelles including the endoplasmic reticulum, nucleus, and mitochondria. However, the role of BK Ca channels in tumor microenvironment including hypoxia is yet to be explored. Hypoxia promotes vessel growth by upregulating multiple proangiogenic pathways that mediate key aspects of endothelial, stromal, and vascular support cell biology. [14] In general, uncontrolled cancer growth and subsequent neoangiogenesis lead to hypoxic tumor microenvironment. [15] VEGF expression increases dramatically in hypoxic conditions due to a number of activated oncogenes that are overexpressed in hypoxia. VEGF induces endothelial cell proliferation, promotes cell migration, and inhibits apoptosis. [16] Deregulated VEGF expression contributes to the development of solid tumors by promoting tumor angiogenesis and to the etiology of several additional diseases that are characterized by abnormal angiogenesis. Consequently, inhibition of VEGF signaling abrogates the development of a wide variety of tumors. [17] The second-generation multitargeted tyrosine kinase inhibitor targets VEGFR, platelet-derived growth factor receptor, and c-kit as key proteins responsible for tumor growth and survival. [18] Pazopanib exhibits good potency against all of the human VEGFRs and closely relate to tyrosine receptor kinases in vitro and demonstrates antitumor activity in several human tumor xenografts. Therefore, VEGFRs are attractive therapeutic targets. [19] Recent work has shown the central role of K + channels affect multiple conditions of the tumor microenvironment including hypoxia and adenosine. [20] It has long been known that the interaction of tumor cells with their host microenvironment, including endothelial cells and the extracellular matrix, plays an important role in tumor growth and invasion. [21, 22] Hypoxia induces the transcriptional activation of signaling pathways and regulates tumor growth through differential alternative splicing. [23] Nonetheless, very little is known about the effect of hypoxia on the alternative splicing of calcium-activated potassium channel subunit alpha-1 (KCNMA1) either in tumor cells or in endothelial cells. Understanding the role of hypoxia in KCNMA1 splicing is extremely crucial to study blood-brain tumor barrier (BTB) function and improve drug delivery. Our previous studies [24] [25] [26] [27] [28] [29] [30] have revealed that human brain microvascular endothelial cells adjacent to glioma cells overexpress BK Ca channels, as opposed to human brain microvascular endothelial cells in normal brain. Our aim is to seek whether the tumor cells (with or without physical [5] VEGF B Embryonic angiogenesis (myocardial tissue specifically)
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KCNMA1 cloning
To overexpress KCNMA1 and α-subunit of BK Ca channel protein, two oligonucleotides: 5'-GAA GCT TAT GGC TGT TGA TGG GTG TTT-3' and 5'-GTC TAG AGG GGA AAT GAG TGG CAG ATA-3', which are adjacent to the start and stop codon of the human BK Ca channel α-subunit sequence (NM 002247.2), were used to amplify a 3.7 kb fragment.
To generate a stable cell line, 2 × 10 5 U-87 cells were transfected with 2 μg of pcDNA6/KCNMA1 using lipofectamine transfection reagent (Invitrogen). Stable clones were selected for 2 weeks in a cell culture medium (Becton, Dickinson and Company, Durham, NC, USA) containing 5 μg/mL blasticidin.
Quantitative PCR
The housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a normalizing gene to correct for differences in the amount of RNAs in each sample. Gene-specific primers and probes for KCNMA1 and GAPDH were obtained from ABI TaqMan Gene Expression Assay (HMBS, Hs006090297_m1; TLR9, Hs900152973_m1) (Applied Biosystems). The quantitative PCR and subsequent data analysis were performed using the M × 4000, a multiplex Quantitative PCR System (Stratagene, Amsterdam, The Netherlands). The quantitative PCR reactions were performed and fluorescence measured during the 60°C-step for each cycle. Data were calculated by comparative Ct method. [34] The KCNAM1 expression level was normalized to the expression level of GAPDH.
Membrane potential assay
The functional activity of BK Ca channels in parental and transfected U-87 cells was measured using the fluorometric imaging plate reader membrane potential assay kit and a specific BK Ca channel activator (50 μM), NS-1619/ NS-004 (1-[5-chloro-2-hydroxyphenyl]-5-trifluoromethyl-1,3-dihydro-2-benzimidazol-2-one) provided by NeuroSearch contact) overexpress KCNMA1 or its splice variants to increase secretion of VEGF to induce angiogenesis.
mateRials and methods

Cell culture
U-87 MG (U-87), Hs683, and LN-18 cells were obtained from American Type Culture Collection (Rockville, MD, USA) and maintained in minimum essential medium Eagle with 10% fetal bovine serum (Invitrogen, Carlsbad, CA, USA).
Coculture in monolayer
The established human brain microvasculature endothelial cell line (HCMEC/D3) of normal brain endothelial phenotype, kindly provided by Dr. Weksler (Weill Medical College, Cornell University, Ithaca, NY, USA). As described by us earlier, [31] HCMEC/D3 cells labeled with PKH2 were cocultured with parental and transfected U-87 and Hs683 cells in rat collagen-1-coated tissue culture dishes for 24-72 h. One set of cocultured cells was placed in an incubator (Thermo Fisher Scientific, Bangalore, India) with 95% N 2 and 5% CO 2 to induce hypoxia while the other set maintained in an incubator with 5% CO 2 to achieve normoxia. The cell lines grown individually were used as a reference in the proposed experiments. Hypoxia was monitored using 2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide (EF5; Thermo Fisher Scientific, Waltham, MA, USA) by flow cytometry as described in the literature. [32, 33] Inhibition of KCNMA1 using tetracycline-repressor system regulated small hairpin RNA To minimize the leakiness, we engineered a vector containing three Tet-repressor binding sites and used H1 A/S (Copenhagen, Denmark), selective agonists of BK Ca channels, on the FlexStation 3 (Molecular Devices, Sunnyvale, CA, USA) as described by us previously. [30, 31] 
Detection of KCNMA1 in coculture under normoxia and hypoxia
Since there is not much known based on our literature search on the expression of BK Ca channels in cocultured brain endothelial cells with the U-87 MG cells, we studied the expression of BK Ca channel α-subunit in hypoxic and normoxic conditions using flow cytometry and fluorescence microscopy. The parental and transfected U-87 MG cells were cocultured with HCMEC/D3 cells labeled with live cell staining dye PKH2 (green fluorescence). The coculture was subjected to normoxic and hypoxic conditions for 48 h and the cells were stained with BK Ca channel α-subunit antibody. Goat anti-rabbit IgG labeled with phycoerythrin were purchased from Abcam (ab72465, ab97070) and Life-Technologies (P2771MP). Phycoerythrin-labeled secondary antibody was used for detection of BK Ca channel α-subunit. The staining protocol was similar for immunofluorescence and flow cytometry. However, the cells were trypsinized and fixed as single cells for flow cytometry analysis, while the cells grew on coverslips for microscopy. Endothelial cells showing green (PKH2) and red (for BK Ca channel) fluorescence were gated, and flow cytometric histograms plotted for red fluorescence and mean fluorescence intensity (represents the BK Ca channel expression) were calculated. The cells were acquired on the guava flow cytometer (Tree Star Inc., Ashland, OR, USA) and analyzed using FlowJo Software (Tree Star Inc.). Phycoerythrin-labeled secondary antibody was used for detection of BK Ca channel α-subunit. The cells were acquired on the Guava flow cytometer and analyzed using FlowJo software (Tree Star Inc.).
Detection of glioma cell growth and invasion
Growth and invasion assays were measured in parental and transfected U-87 cells using BD BioCoat™ growth factor reduced insert plates (Matrigel™ Invasion Chamber 12-well plates) obtained from Becton, Dickinson Company. [35] 
Detection of VEGF secretion and HCMEC/D3 cell proliferation
To prepare conditioned media (CM), untransfected KCNMA1 and KCNMA1 vE22 overexpressing U-87 MG cells were used, with HCMEC/D3 as the control. Cells (1.5 × 10 6 cells/dish) were seeded on culture dishes. After incubation for 24 h, the cell layer was washed with phosphate-buffered saline (twice) to remove serum components. The dishes were then incubated with endothelial growth media (Lonza, Cohasset, MN, USA) under hypoxic conditions (to facilitate VEGF secretion). A separate set of dishes were treated with Iberiotoxin (10 nM) obtained from Sigma. After incubation for 48 h, the culture medium was collected and centrifuged at 1.12 × g for 5 min and filtered through a 0.2-μm filter to remove cells and cell debris, and the filtrate served as CM. As described by us, [31] we determined the role of VEGF in modulating endothelial cell proliferation via altered BK Ca channel expression, brain microvascular endothelial cells (HCMEC/ D3, gift from Dr. Weksler, Cornell University, Cornell, NY, USA) were grown in the presence of VEGF (secreted), added VEGF (Sigma) and iberiotoxin.
VEGF levels in CM were measured using human VEGF enzyme-linked immunosorbent assay kit (Invitrogen). The shKCNMA1 with or without Dox (D9891, Sigma) at 1 mg/mL was added to HCMEC/D3 cells, grown in the media containing VEGF. The cell proliferation and invasion were measured to delineate the role of VEGF in KCNMA1. Cell proliferation was determined by growth curve and MTT assay, and BK Ca channel expression by flow cytometry as described by us. [35] In noncontact experiments, HCMEC/D3 cells were grown in CM derived from parental and transfected U-87 cells. For contact experiments, labeled-HCMEC/D3 cells were grown with parental and transfected U-87 MG cell line and labeled-HCMEC/D3 cells counted on hemocytometer using Nikon inverted fluorescence microscope (Nikon Inc., Melville, NY, USA).
Detection of glioma growth and invasion
We studied the effect of BK Ca channels on the invasiveness of glioma cells by pharmacological inhibition using iberiotoxin and by shRNA-mediated knockdown of its α-subunit. Invasion was assessed using the Matrigel invasion assay as described by us. [31] BD BioCoat™ growth factor reduced insert plates (Matrigel™ Invasion Chamber; Becton, Dickinson and Company) were prepared by rehydrating the BD Matrigel™ matrix coating in the inserts. Dulbecco's modified Eagle medium containing chemoattractant (1% fetal bovine serum) was added to the lower wells of the plate, and cell suspension in serum-free medium was added in each insert well. For induction of shRNA, Dox (1 mg/mL) was added to the cell culture medium in both upper and lower chambers along with cells and chemoattractant solution. Cells on the lower surface of the insert were stained with crystal violet and each transwell membrane mounted on a microscopic slide for visualization and analysis. The number of tumor cells that migrated from the upper to the lower side of the filter was counted. The data were expressed as the percent invasion through the membrane relative to the migration through the control membrane. Invasion percent = mean number of treated cells invading through the Matrigel insert membrane/mean number of cells migrating through control insert membrane × 100.
Detection of tumor cell-induced VEGF secretion in endothelial cells
To test this hypothesis, HCMEC/D3 cells were incubated with CM obtained from U-87 MG cells overexpressing KCNMA1 and KCNMA1 vE22. Internal controls were HCMEC/D3 cells grown in the absence of CM and cells treated with VEGF (Sigma). Following 48 h of treatment with CM, cells were trypsinized, counted, and fixed with 4% paraformaldehyde and stained with BK Ca channel α-subunit antibody for flow cytometry assay and microscopy following immunostaining.
Vascular endothelial growth factor measurement
To determine whether modulation of KCNMA1 affects VEGF secretion, parental and transfected cells were seeded into six-well cell clusters at 3 × 10 6 cells per well. After 48 h of incubation, the cell culture medium was collected to measure secreted VEGF using mouse monoclonal antibodies against vimentin (1:100; Thermo Fisher Scientific, Fremont, CA, USA), and cells were subsequently detached and counted. We measured VEGF levels in culture media obtained from wild-type and KCNMA1 shRNA transfected U-87 MG cells to establish a role for BK Ca channels in altering VEGF secretion. VEGF levels were measured using the human VEGF ELISA kit (Invitrogen) and expressed as picograms per million cells (pg/10 6 ).
Detection of BK Ca channel expression, activity, KCNMA1 splicing in hypoxia
The effect of hypoxia on BK Ca channel expression was studied by immunofluorescence staining of glioma cells growing under hypoxia for 48 h (95% N 2 and 5% CO 2 ) and normoxia (5% CO 2 ). Immunoblotting of BK Ca channel protein was performed on paraformaldehyde-fixed cells, which were permeabilized with 0.05% Triton-×100 in phosphate-buffered saline for 8 min on ice. Membranes were washed with Tween-tris-buffered saline four times for 15 min each and incubated with anti-mouse peroxidase-conjugated secondary antibody (1:1000 dilution; Santa Cruz, CA, USA) for BK Ca channel detection and anti-rabbit peroxidase-conjugated secondary antibody (1:5000 dilution; Amersham, CA, USA) for 1 h at 37°C. Cells were then washed and incubated with fluorescein isothiocyanate-labeled secondary antibody for 60 min at 4°C. Images were acquired using a Nikon inverted microscope, Photometrics coolsnap HQ2 charge couple device camera, and Metamorph software. RNA was extracted using TRIzol reagent (Invitrogen). Primer pairs spanning the entire gene (27 exons) were used to identify differential splicing events under normoxia and hypoxia by quantitative PCR. We also measured the invasive potential of cells exposed to hypoxia and normoxia.
Detection of KCNMA1 modulation on tumor formation
We injected 2 × 10 6 parental and transfected U-87 cells subcutaneously into both the flanks of 4-6-week-old female athymic nude mice (weighing 18-20 g, n = 5/group) obtained from Charles River (Woburn, MA, USA). Mice were randomly assigned into control and treatment groups. Tumors were measured once a week for 12 weeks, and volume calculated using the formula (V = 0. 
Statistical analysis
One-way analysis of variance and multitest correction for P values were applied to all the in vitro (in triplicate) and in vivo (n = 5/group) experimental data. P values determined in cells (low-grade vs. high-grade glioma as well as shKCNMA1 transfected vs. non-transfected U87 cells) acted as the candidate variable in the analysis of variance model. The error bars shown in figures represent the standard deviation (SD). The SPSS software 20 (IBM, Armonk, NY, USA) was used for the analyses. All the in vitro (in triplicate repeated twice) and in vivo (n = 5/group) experimental data were subjected to one-way analysis of variance, nonparametric Z-test, and multitest correction for P values in tissue type (low-grade vs. high-grade glioma as well as shKCNMA1-transfected vs. nontransfected U-87 cells) as the candidate variable in the one-way analysis of variance model. The error bars shown in the figures represent the SD. P < 0.05 was considered statistically significant.
Results
Effect of BK Ca channels/KCNMA1 on VEGF secretion and HCMEC/D3 cell proliferation
We observed a significant increase (P < 0.05) in human brain microvascular endothelial cells (HCMEC/D3) proliferation in the presence of CM obtained from U-87 MG cells overexpressing KCNMA1 vE22 [ Figure 4A ], compared to HCMEC/D3 cells grown in the absence of VEGF. In contrast, CM from KCNMA1-silenced U-87 MG cells did not affect HCMEC/D3 cell proliferation. BK Ca channel expression increased nearly two-fold in endothelial cells grown in CM from U-87 MG cells overexpressing KCNMA1 vE22 [ Figure 4B ]. These results suggested that tumor cells secrete certain growth factors including VEGF, which alter BK Ca channels expression on endothelial cells that might stimulate their proliferation. VEGF also caused an increase in BK Ca channel expression in HCMEC/D3 cells.
Effect of hypoxia on BK Ca channel expression and activity
As seen in Figure 5A , high-grade glioma cell lines LN-18 and U-87 MG expressed higher levels of BK Ca channel α-subunit when exposed to hypoxic conditions. The increased expression of BK Ca channel α-subunit under hypoxia corroborated with increased activity of BK Ca channels [ Figure 5B ]. We also measured the invasive potential of cells exposed to hypoxia and demonstrated that tumor cells were more invasive under hypoxia compared to normoxia. Furthermore, the migration of U-87 MG and LN-18 cells in hypoxia was decreased by 90% when BK Ca channels were inhibited by reagent (Invitrogen). Primer pairs spanning the entire gene (27 exons) were used to identify differential splicing events under normoxia and hypoxia by quantitative PCR. Figure 7 shows the differential expression of exon (PCR product intensities and additional bands, shown by yellow arrowheads) under normoxia and hypoxia, which suggests that alternative splicing of KCNMA1 might be stimulated by hypoxia.
In vivo effect of KCNMA1 inhibition on tumorigenicity
As compared to the untransfected group [ Figure 8A ], shKCNMA1-transfected group showed reduced tumor growth [ Figure 8B upper panel]. Interestingly, the removal of Dox on week 6 reactivated the KCNMA1 promoting tumor growth [ Figure 8B bottom panel]. In wild-type group, tumor growth formation and growth were swift and reached (500 mm 3 ) by 4 weeks, prompting euthanasia, compared to negligible tumor growth in the KCNMA1-silenced group, which remained insignificant until the 6 th week when Dox was withdrawn. However, from the 6 th week onward tumor growth was dramatic and reached 350 mm 3 by the 11 th week, prompting euthanasia.
disCussion
BK Ca channels are overexpressed on brain tumor capillary endothelial cells and serve as the convergence point for various BTB-permeability-related signaling pathways. [24] [25] [26] [27] [28] [29] [30] [31] These critical observations prompted us to determine whether these channels play an important role in BTB permeability regulation in human brain tumor xenograft where permeability increase was caused by NS-1619 that was attenuated by iberiotoxin (IC 50 = 68 nM), a selective inhibitor of BK Ca channels. [28] VEGF has been shown to increase BBB permeability by affecting the tight junctions between endothelial cells, i.e., via the paracellular route. [28] Nevertheless, it is not clear whether VEGF has any direct effect on BK Ca Iberiotoxin [ Figure 5C ]. These results suggest that hypoxia increases BK Ca channel-mediated migration of glioma cells.
Effect of KCNMA1/BK Ca channel suppression on glioma invasion and growth
The shRNA-induced inhibition of KCNMA1 expression significantly inhibited the invasion of transfected U-87 MG cells compared to untransfected cells (P < 0.01) [ Figure 3A ]. In addition, shRNA-mediated silencing of KCNMA1 showed a 70% reduction in growth of U-87 MG cells [ Figure 3B ] as compared to untransfected U-87 MG cells. We found that the invasive potential of glioma cells exposed to hypoxia was greater under hypoxia compared to normoxia.
Effect of KCNMA1/BK Ca channel expression and vascular endothelial growth factor on endothelial cell proliferation
We measured VEGF levels in culture media obtained from wild-type and KCNMA1shRNA transfected U-87 MG cells to establish a role for BK Ca channels in altering VEGF secretion. Addition of VEGF increased endothelial cell proliferation, which was inhibited by Iberiotoxin [ Figure 6A ], suggesting a role for BK Ca channels in VEGF-mediated endothelial cell proliferation. VEGF also caused an increase in BK Ca channel expression in HCMEC/D3 cells [ Figure 6B ]. A significant decrease in VEGF secretion was observed in U-87 cells where KCNMA1 was silenced, and in Hs683 cells, which is known to express lower level of (KCNMA1) as compared with U-87 MG cells (P < 0.01) [ Figure 6C ]. These results suggest that VEGF secretion may be influenced by KCNMA1 expression levels.
Hypoxia and calcium-activated KCNMA1 splicing
The effect of hypoxia on KCNMA1 splicing was studied by exposing glioma and endothelial cells to hypoxia and normoxia as described above. RNA was extracted using TRIzol 
BK Ca channels and hypoxia
Hypoxia upregulates (Ca 2+ ) i , activates BK Ca channels [36] and induces VEGF in melanoma, [37] all of which are necessary for the tumor growth, invasion, metastasis, and angiogenesis. Studies have shown that VEGF acts as an autocrine growth and survival factor for VEGFR-expressing tumor cells. [3] It is known that VEGF effect is attributable to a paracrine mechanism by tumor cells [38] and is responsible for initiating signal transduction pathways within the endothelial cells. Autophosphorylation of key sites within the cytoplasmic domain of VEGFR induces several cellular signaling pathways leading to angiogenesis. [39] More specifically, IP3 mobilizes (Ca 2+ ) i , which activates BK Ca channels and increases proliferation of endothelial cells. In addition, PI3K pathway-mediated release of nitric oxide (NO) from endothelial cells has been shown to be an essential mediator of VEGF-A (VEGF165)-induced angiogenesis. We have shown that NO activates BK Ca channels on endothelial cells [28] leading to their proliferation and increased BTB permeability in glioma models. The effect of BK Ca channels on tumor cells are shown to be directly affecting number of different cellular processes such as progression, perturbation of membrane potential, sensitivity to (Ca 2+ ) i balance, cell proliferation, invasion and metastasis, and survival. [40] In addition a slight increase in (Ca 2+ ) i activates BK Ca channels directly. [41] The investigation of the role of BK Ca channels in association with VEGF in tumor cells in promoting angiogenesis is long overdue. The regulatory network between BK Ca channels and key processes such as angiogenesis that shape the tumor microenvironment could provide the scientific basis for the implementation of novel anticancer strategies. We propose that VEGF via endothelial NO synthase, (Ca +2 ) i , and NO activates BK Ca channels and increases proliferation of endothelial cells.
It has long been known that the interaction of tumor cells with their host microenvironment, including endothelial cells and the extracellular matrix, plays an important role in tumor growth and invasion. [42] Hypoxia induces the transcriptional activation of signaling pathways and regulates tumor growth. [43] Tumor-endothelial cell interaction in hypoxia has been shown to cause differential alternative splicing. [44] Nonetheless, very little is known about the effect of hypoxia on the alternative splicing of KCNMA1 either in tumor cells or in endothelial cells. Understanding the role of hypoxia in KCNMA1 splicing is extremely crucial as glioma cells interact with brain microvascular endothelial cells to migrate to normal brain and form microsatellites. These processes have implications on the BTB function and drug delivery. Our previous studies [28] [29] [30] [31] have revealed that human brain microvascular endothelial cells adjacent to glioma cells overexpress BK Ca channels, as opposed to human brain microvascular endothelial cells in normal brain. Even so, whether the tumor cell (with or without physical contact) secretes certain factors that induce endothelial cells to overexpress KCNMA1 or its splice variants remains to be thoroughly investigated. Several studies have shown that endothelial cells proliferate following stimulation by VEGF and/or basic fibroblast growth factor to form new blood vessels. [45, 46] Also, interleukin-8 or C-X-C motif chemokine ligand 8 assists in accelerating the proliferation and migration of the cancerous cells. It also inhibits apoptosis of the cells which leads to the continual survival of the cells even in the most extremes of condition, where the cells are not able to derive an optimum amount of oxygen and nutrition from the blood plasma. This is precisely the reason for which a number of anticancer drugs are not able to control invading cancer cells. A review discussed how pediatric brain tumors regulate angiogenesis to obtain a vascular supply, what types of inhibitors are available, how different classes of inhibitors work, the types of resistance possible, how rapidly these inhibitors may work, and what surrogate markers of activity are available to follow responses. [47] Altered ion channels could play a pivotal role in physiological angiogenesis in including cancer. [48] BK Ca channel inhibitor modulated the tumorigenic ability of hormone-independent breast cancer cells via the Wnt pathway. [49] Our work shows an association between the BK Ca channel isoform expression and VEGF secretion by glioma cells, which is exacerbated under hypoxia that has implications for vascular permeability and anticancer drug delivery. We unraveled the expression pattern of KCNMA1 and VEGF in tumor microenvironment [ Figure 5 ] and splicing patterns of KCNMA1 [ Figure 7 ] under normoxia and hypoxia alone and in coculture with brain microvascular endothelial cells (HCMEC/D3).
Other researchers have found that the modulation of BK Ca channel activity or expression by the hypoxic environment may participate in the acquisition of the aggressive phenotype observed in glioblastoma multiforme cells residing in a hypoxic environment. [50] Channelopathy due to altered ion channel expression/function exacerbates angiogenesis signaling. [21] We showed the association between the BK Ca channel isoform expression and VEGF secretion by breast tumor cells, which might be exacerbated under hypoxia [ Figure 6 ]. Thus, altered tumor vasculature might affect vascular permeability for anticancer drug delivery. There is a need to study the mechanism how KCNMA1 and its splice variant KCNMA1 ΔE2 expression under normoxia and hypoxia affect neovascularization. For example, we used U-87 cells alone and in coculture with brain endothelial cells to study the role of KCNMA1 alternative splicing in glioma biology. Therefore, discovery and validation of KCNMA1 alternate splice variants in brain tumors may serve as new tools for the diagnosis and classification of brain tumor patients with high risk of aggressive phenotype like glioblastoma multiforme. Such splice variations in a number of genes were shown to increase malignancy and could precede clinical cancer diagnosis. [51] We constructed a potential VEGF signaling pathway adapted from KEGG-VEGF signaling pathway by activation and suppression of KCNMA1 in U-87 cells. Then, we reported that FLT1, HMCN1 were upregulated by KCNMA1 activation and AKT2, KDR, MAPK11, PXN, SPHK1, NFAT5, and NFATC1 were downregulated when KCNMA1 was suppressed. [40] The pathway suggests that KCNMA1/BK Ca channels appear to play a role in VEGF secretion and neovascularization in brain tumors. Hence, it may be expected that use of BK Ca channels modulators may be considered for developing novel therapeutic strategies against brain tumors.
The presence of hypoxia appears to be a common feature of brain tumors and primarily responsible for their poor response to treatment. [21] Hypoxia is also shown to cause the leakage of tumor blood vessels by inducing VEGF expression, which promotes new blood vessel formation (angiogenesis) and increases vascular permeability during tumor growth. [14] Hypoxia transforms tumor cells to be more malignant, aggressive, genetically unstable, and less susceptible to apoptosis, rendering resistance to a wide range of anticancer therapies. Our data showed that brain tumors cells exposed to hypoxia may also induce distinct molecular changes like the overexpression of BK Ca channels/KCNMA1 splice variants and increased VEGF secretion that promotes neoangiogenesis. Cancer is more likely be caused by channelopathy along with other oncogenic factors.
[52] The brain tumor microenvironment alters BK Ca channels expression on endothelial cells that might stimulate their proliferation by increased VEGF secretion by tumor cells.
ConClusion
Perhaps, the discovery and validation of brain-specific metastasis-associated KCNMA1 alternate splice variants will serve as new tools for the diagnosis and prognosis of aggressive glioma phenotype. Our results clearly show that KCNMA1 exacerbate glioma growth and angiogenesis in hypoxia. Taken together, these experiments show a critical role of KCNMA1 expression on VEGF secretion by glioma cells and endothelial cell proliferation in normoxia and hypoxia. These studies will contribute to a fundamental understanding of the role of KCNMA1 in glioma microenvironment and angiogenesis.
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